1 – 4 of 4
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Donanemab in Early Symptomatic Alzheimer Disease : The TRAILBLAZER-ALZ 2 Randomized Clinical Trial
- Contribution to journal › Article
- 2018
-
Mark
Association of cerebral amyloid-β Aggregation with cognitive functioning in persons without dementia
Jansen, Willemijn J. ; Ossenkoppele, Rik LU ; Tijms, Betty M. ; Fagan, Anne M. ; Hansson, Oskar LU
; Klunk, William E.
; Van Der Flier, Wiesje M.
; Villemagne, Victor L.
; Frisoni, Giovanni B.
and Fleisher, Adam S.
, et al.
(2018)
In JAMA Psychiatry
75(1).
p.84-95
- Contribution to journal › Article
-
Mark
Prevalence of the apolipoprotein E ε4 allele in amyloid β positive subjects across the spectrum of Alzheimer's disease
Mattsson, Niklas LU
; Groot, Colin
; Jansen, Willemijn J.
; Landau, Susan M.
; Villemagne, Victor L.
; Engelborghs, Sebastiaan
; Mintun, Mark M.
; Lleo, Alberto
; Molinuevo, José Luis
and Jagust, William J.
, et al.
(2018)
In Alzheimer's and Dementia
14(7).
p.913-924
- Contribution to journal › Article
- 2015
-
Mark
Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis.
- Contribution to journal › Article